ArticleMolecular biology reports2025
Validation of a dual-purpose conventional PCR strategy for SARS-CoV-2 detection and lineage screening in resource-limited laboratories.
Article in Molecular biology reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
purposeAffordable molecular tools for SARS-CoV-2 surveillance are crucial, particularly in settings where access to advanced technologies is limited. This study aimed to validate a dual-purpose strategy based on conventional PCR and polyacrylamide gel electrophoresis for both diagnosis and lineage screening.
methodsFifty-five nasopharyngeal swab samples were analyzed through RNA extraction, reverse transcription, and conventional PCR targeting the SARS-CoV-2 spike (S) gene. Amplicons were visualized on 6% polyacrylamide gels, and the diagnostic results were compared with those of RT‒qPCR. Fragment size shifts via electrophoresis were used for lineage inference and confirmed via Sanger sequencing.
resultsThe method demonstrated 100% concordance with RT‒qPCR for both diagnostic detection and accurate lineage classification in all analyzed samples. Characteristic gel migration patterns allowed identification of Omicron sublineages, and two samples presented unique mutational profiles not previously recorded in databases at the time of sampling. One of them matched the BA.2.86 lineage later reported in July 2024, indicating the method's potential for early variant detection. The approach also enabled multiplex PCR and internal control verification using a human LDLR gene fragment.
conclusionThis dual-purpose PCR strategy offers a cost-effective, scalable, and technically accessible alternative for SARS-CoV-2 surveillance in low-resource settings. Its high diagnostic reliability and ability to detect emerging variants through amplicon profiling support its implementation as a screening tool, pending broader validation across diverse populations.
Indexed as
Identifiers
41075075What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.